Publication related to RSI or an RSI staff member

Men having sex with men donor deferral risk assessment: an analysis using risk management principles.

This article discusses issues associated with the lifetime deferral from donating blood of men having sex with men (MSM), in the context of well-established risk management principles, including ethical considerations associated with the risk-based approach to social policy matters. Specifically, it deals with the questions about the rationale for the existing policy in Canada of lifetime deferral for MSM, a rationale applied in practice by blood collection agencies and supported by the regulatory authority of Health Canada. We identify several alternative time frames for MSM deferral: sexual abstinence over either a 10-, 5-, or 1-year period or no deferral. Two options are selected for more complete discussion, namely, abstinence for a period of either 1 or 5 years before donation. The available evidence about estimated residual risk (RR)-that is, the risk remaining after various safeguards for blood are applied-strongly suggests that choosing a 1-year deferral period for MSM would almost certainly give rise to an incremental risk of transfusion-transmitted infection (TTI), over existing levels of risk, for blood recipients. The report argues that, under these circumstances, such a policy change would represent an unethical type of risk transfer, from one social group to another, and therefore would be unacceptable. The evidence is less clear when it comes to a change to either a 10- or 5-year deferral period. This is the case in part because the current level of RR is so low that there are, inevitably, substantial ranges of uncertainties associated with the risk estimation. There is no firm evidence that such a change in the deferral period for MSM would result in an incremental level of risk, although the possibility of a very small increase in risk cannot be entirely ruled out. Under these circumstances, other social policy issues, relevant to the idea of changing the deferral period for MSM, become worthy of additional consideration.

Authors

  • Leiss, William, Leiss W, McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada. wleiss@uottawa.ca

  • Tyshenko, Michael, Tyshenko M,

  • Krewski, Daniel, Krewski D,

YEAR OF PUBLICATION: 2008
SOURCE: Transfus Med Rev. 2008 Jan;22(1):35-57. doi: 10.1016/j.tmrv.2007.09.002.
JOURNAL TITLE ABBREVIATION: Transfus Med Rev
JOURNAL TITLE: Transfusion medicine reviews
ISSN: 0887-7963 (Print) 0887-7963 (Linking)
VOLUME: 22
ISSUE: 1
PAGES: 35-57
PLACE OF PUBLICATION: United States
ABSTRACT:
This article discusses issues associated with the lifetime deferral from donating blood of men having sex with men (MSM), in the context of well-established risk management principles, including ethical considerations associated with the risk-based approach to social policy matters. Specifically, it deals with the questions about the rationale for the existing policy in Canada of lifetime deferral for MSM, a rationale applied in practice by blood collection agencies and supported by the regulatory authority of Health Canada. We identify several alternative time frames for MSM deferral: sexual abstinence over either a 10-, 5-, or 1-year period or no deferral. Two options are selected for more complete discussion, namely, abstinence for a period of either 1 or 5 years before donation. The available evidence about estimated residual risk (RR)-that is, the risk remaining after various safeguards for blood are applied-strongly suggests that choosing a 1-year deferral period for MSM would almost certainly give rise to an incremental risk of transfusion-transmitted infection (TTI), over existing levels of risk, for blood recipients. The report argues that, under these circumstances, such a policy change would represent an unethical type of risk transfer, from one social group to another, and therefore would be unacceptable. The evidence is less clear when it comes to a change to either a 10- or 5-year deferral period. This is the case in part because the current level of RR is so low that there are, inevitably, substantial ranges of uncertainties associated with the risk estimation. There is no firm evidence that such a change in the deferral period for MSM would result in an incremental level of risk, although the possibility of a very small increase in risk cannot be entirely ruled out. Under these circumstances, other social policy issues, relevant to the idea of changing the deferral period for MSM, become worthy of additional consideration.
LANGUAGE: eng
DATE OF PUBLICATION: 2008 Jan
DATE COMPLETED: 20080215
DATE REVISED: 20071207
MESH DATE: 2008/02/19 09:00
EDAT: 2007/12/08 09:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

Michael G. Tyshenko

Senior Health Risk Analyst

Dr. Michael G. Tyshenko is a Senior Health Risk Analyst at Risk Sciences International (RSI), where he has contributed since 2018 to some of the organization’s most complex and cross-cutting public health risk projects. As RSI’s lead on chemical peer...
Read More about Michael G. Tyshenko

William Leiss


As a Senior Advisor and Associate Expert with Risk Sciences International, Dr. Leiss contributes unparalleled insight into the design, delivery, and evaluation of risk communication strategies for government, regulatory bodies, and civil society. His legacy work in building public trust...
Read More about William Leiss